LDL-P

Other names: LDL P

Optimal result: 0 – 1000 nmol/L

In general, the result is interpreted within the framework of a lipid profile and its associated risk. If you have an increased LDL-P, this finding will add to your risk of developing cardiovascular disease above and beyond the risk associated with LDL cholesterol.

It is important to remember that LDL subfraction testing is not diagnostic, not endorsed by any medical societies, and not approved by the FDA. It attempts to evaluate your risk of developing CVD, but it cannot predict the development or severity of disease in a particular person. For this reason, LDL subfraction results should not be considered when making decisions about treatment or lifestyle changes.

How can I decrease my LDL-P?

LDL-P can be altered by adopting a reduced-calorie diet, losing excess weight, and exercising regularly. The use of lipid-lowering drugs such as statins and PCSK9-inhibitors will significantly reduce LDL-P.

Lipoproteins are particles that transport fats throughout the body. These particles are essential and carry a combination of proteins, vitamins, cholesterol, triglyceride, and phospholipid molecules.

The composition of a lipoprotein particle changes as it circulates in the blood. Some molecules are removed and others are added, resulting in lipoprotein particles with variable amounts of cholesterol. Low-density lipoprotein particles (LDL-P) are bi-products of fat transport that remain in circulation for an extended time. While in circulation, LDL-P can penetrate the artery wall and get stuck, forming a fatty plaque. These plaques can build over time and lead to blockages, resulting in heart attacks and strokes.

Lipoproteins are particles that transport fats throughout the body. These particles are essential and carry a combination of proteins, vitamins, cholesterol, triglyceride, and phospholipid molecules.

The composition of a lipoprotein particle changes as it circulates in the blood. Some molecules are removed and others are added, resulting in lipoprotein particles with variable amounts of cholesterol. Low-density lipoprotein particles (LDL-P) are bi-products of fat transport that remain in circulation for an extended time. While in circulation, LDL-P can penetrate the artery wall and get stuck, forming a fatty plaque. These plaques can build over time and lead to blockages, resulting in heart attacks and strokes. The likelihood of an LDL-P getting trapped in the artery wall increases when more LDL-P are in the blood. Traditional lipid testing measures the amount of LDL cholesterol (LDL-C) present in the blood, but it does not evaluate the number of LDL particles (LDL-P). LDL-P is often used to get a more accurate measure of LDL due to the variability of cholesterol content within a given LDL. Studies have shown that LDL-P more accurately predicts risk of cardiovascular disease than LDL-C. Researchers think that increased LDL-P could be one of the reasons that some people have heart attacks even though their total cholesterol and LDL cholesterol levels are not particularly high.

-------------------

- LDL-P is the direct measure of low density lipoprotein particles - the causal link between high levels of LDL-P and development of cardiovascular disease (CVD) is well established.

- Studies have demonstrated per-particle cholesterol amount varies in patients with type II diabetes, statin-treated patients, and those with cardiometabolic risk factors (CMR) listed below: [1, 2 , 3]

                    Age: men ≥45 yrs, women ≥ 55 yrs) [4]

                    Elevated BP: (≥130/≥85 mmHg; on antihypertensive medication) [5]

                    Abdominal obesity/waist circumference: male ≥ 40” (Asian ≥ 35”), female ≥ 35” (Asian ≥ 31”) [5]

                    Elevated triglycerides: (≥150 mg/dL), low HDL (men < 40 mg/dL, women < 50 mg/dL), increased numbers of small dense                     LDL particles, [2, 5], on drug treatment for elevated triglycerides or HDL-C

                    Elevated fasting blood glucose: (≥ 100 mg/dL), [5] on drug treatment for elevated glucose

                    Insulin resistance: (IR) [2]

- Many expert panels recommend use of LDL-P values to optimize treatment decisions in these at-risk patients. [2, 6]

- NMR LipoProfile Test is FDA cleared for use in conjunction with other lipid measurements and clinical evaluation to aid in the management of lipoprotein disorders associated with CVD. [7]

References:

1. Toth PP, Grabner M, Punekar RS et al. Cardiovascular risk in patients achieving lowdensity lipoprotein cholesterol and particle targets. Atherosclerosis. 2014 (235)585-591. [1]

2. Brunzell JD, Davidson M, Furberg CD, et al. Lipoprotein management in patients with cardiometabolic risk. Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care. 2008 April; (31)4:811-82. [2]

3. Sniderman AD, Williams K, Contois JH et al. A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular risk. Circ Cardiovasc Qual Outcomes. 2011;4:337-345. [3]

4. National Heart, Lung, and Blood Institute. Executive Summary. The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), National Institutes of Health. May 2001. NIH publication 01-3670; 1-28. [4]

5. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute scientific statement: Executive Summary, Circulation. 2005; 112 e285-e290. [5]

6. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, Dagogo-Jack S, DeFronzo RA, Einhorn D, Fonseca VA, Garber JR, Garvey WT, Grunberger G, Handelsman Y, Henry RR, Hirsch IB, Jellinger PS, McGill JB, Mechanick JI, Rosenblit PD and Umpierrez GE. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm - 2016 Executive Summary. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2016;22:84-113. [6]

7. NMR LipoProfile® [package insert]. Raleigh, NC: Laboratory Corporation of America; 2015. [7]

LDL-P
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond LDL-P — 10,000+ markers explained
One LDL-P result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro